Physician

Amanda Judith Podolski, M.D.

According to 2025 Medicare claims, Amanda Podolski, M.D. (NPI: 1932510260) practices hematology/oncology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is VALLEY PHYSICIAN SERVICES PC (NPI: 1467815928; TIN: 465285330) and primary practice location at 07652-3627. Podolski is affiliated with the ColigoCare, LLC (ACO ID: A3591), participating under the MSSP model.

Podolski's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 604 traditional Medicare patients, billed 3,022 HCPCS/CPT codes, and received $183,558 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,101 prescription claims across 553 beneficiaries totaling $3,252,898 in drug costs, led by Ibrance (Palbociclib). DME data shows 107 claims. Open Payments data shows 14 records totaling $140,902. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $32,664 to $183,558. Similarly, Part D prescription costs have risen steadily, from $14,006 to $3,252,898. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	258	536	$32,664
2021	607	2,095	$144,703
2022	604	2,481	$161,915
2023	583	2,660	$169,314
2024	604	3,022	$183,558

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	70	393	$14,006
2016	112	743	$30,714
2017	101	772	$238,052
2018	52	243	$300,186
2019	65	259	$475,390
2020	216	429	$394,911
2021	476	1,981	$921,283
2022	500	2,560	$1,069,686
2023	528	2,656	$1,832,155
2024	553	3,101	$3,252,898

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	82	$6,806
2022	27	134	$7,987
2023	N/R	72	$14,007
2024	12	107	$3,678

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	372	975	$107
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	153	177	$72
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	82	239	$71
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	390	809	$15
36415	Insertion of needle into vein for collection of blood sample	233	551	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	91	2,548	$1,423,899
Kisqali	Ribociclib Succinate	20	560	$326,530
Verzenio	Abemaciclib	18	504	$272,180
Zejula	Niraparib Tosylate	14	420	$262,848
Tukysa	Tucatinib	12	360	$226,612

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	46	$1,693
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	12	13	$1,219
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	36	$616
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	12	$150

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	0	$0	N/R
Research Payments	Reported research-related payment or transfer-of-value amount.	14	$140,902	Merck Sharp & Dohme LLC
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amanda Judith Podolski, M.D.?

Tedicare shows public-source Medicare data for Amanda Judith Podolski, M.D. (NPI 1932510260), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amanda Judith Podolski, M.D. have ACO affiliation data?

Amanda Judith Podolski, M.D. is shown with ACO affiliation data for ColigoCare, LLC (MSSP, ACO ID A3591).

What billing organization is linked to Amanda Judith Podolski, M.D.?

Amanda Judith Podolski, M.D. is linked to VALLEY PHYSICIAN SERVICES PC (billing NPI 1467815928) in the available physician profile data.

Does Amanda Judith Podolski, M.D. have Open Payments data?

Amanda Judith Podolski, M.D. has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.